Evidence map›Paper›PMID 21562921›Full record

ArticleCerebellum (London, England)2011

Cerebellar nicotinic cholinergic receptors are intrinsic to the cerebellum: implications for diverse functional roles.

Jill R Turner, Pavel I Ortinski, Rachel M Sherrard, Kenneth J Kellar

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cerebellum (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Jill R TurnerDepartment of Pharmacology, Georgetown University, Washington, DC 20057, USA.
Pavel I Ortinski
Rachel M Sherrard
Kenneth J Kellar
Georgetown University · USUniversity of Western Australia · AU

Funding

Pharmacology and Regulation of Nicotinic Receptor SubtypesR01DA012976 · NIDA · GEORGETOWN UNIVERSITY · PI KELLAR, KENNETH J · 2001 to 2012
$4.0M
Training in Neural Injury &PlasticityT32NS041218 · NINDS · GEORGETOWN UNIVERSITY · PI MARK P BURNS, Kathleen Anne Maguire-Zeiss · 2001 to 2026
$3.5M
Pharmacogenomic Analysis of Nicotine DependenceR00DA032681 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TURNER, JILL R. · 2014 to 2016
$741k
Pharmacology and Regulation of Nicotinic Receptor SubtypesR56DA012976 · NIDA · GEORGETOWN UNIVERSITY · PI KELLAR, KENNETH J · 2007 to 2007
$349k
NIDA NIH HHS DA012976NIDA NIH HHS R00 DA032681NIDA NIH HHS R01 DA012976NIDA NIH HHS R56 DA012976NINDS NIH HHS NIH-T32-NS41218NINDS NIH HHS T32 NS041218
6 · The paper itself

Abstract

Although recent studies have delineated the specific nicotinic subtypes present in the mammalian cerebellum, very little is known about their location or function within the cerebellum. This is of increased interest since nicotinic receptors (nAChRs) in the cerebellum have recently been implicated in the pathology of autism spectrum disorders. To begin to better understand the roles of these heteromeric nAChRs in the cerebellar circuitry and their therapeutic potential as targets for drug development, we used various chemical and stereotaxic lesion models in conjunction with slice electrophysiology to examine how specific heteromeric nAChR subtypes may influence the surrounding cerebellar circuitry. Using subunit-specific immunoprecipitation of radiolabeled nAChRs in the cerebella following N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride, p-chloroamphetamine, and pendunculotomy lesions, we show that most, if not all, cerebellar nicotinic receptors are present in cells within the cerebellum itself and not in extracerebellar afferents. Furthermore, we demonstrate that the β4-containing, but not the β2-containing, nAChRs intrinsic to the cerebellum can regulate inhibitory synaptic efficacy at two major classes of cerebellar neurons. These tandem findings suggest that nAChRs may present a potential drug target for disorders involving the cerebellum.

Indexed as

AnimalsCerebellumMaleNicotinic AgonistsPresynaptic TerminalsRatsRats, Sprague-DawleyReceptors, NicotinicSynaptic TransmissionNicotinic AgonistsReceptors, Nicotinic

Identifiers

PMID21562921
PMCPMC5094176
OpenAlexW1997149397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.